New Zealand markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.40-0.15 (-1.30%)
At close: 04:00PM EDT
11.46 +0.06 (+0.51%)
After hours: 07:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-3,644
-28,239
-65,904
-71,648
-75,749
Depreciation & amortisation
8,413
8,332
7,113
5,496
3,942
Stock-based compensation
7,218
6,187
5,215
3,488
2,855
Change in working capital
-22,115
-10,123
-18,286
-51,680
-33,781
Accounts receivable
-23,103
-11,916
13,072
-15,340
-9,767
Inventory
-13,747
-9,626
-38,556
-43,188
-28,471
Accounts payable
4,559
3,839
800
1,356
1,899
Other working capital
15,907
3,819
-73,419
-125,880
-114,730
Other non-cash items
5,072
6,287
5,257
1,754
1,640
Net cash provided by operating activities
21,305
8,800
-59,508
-112,369
-102,003
Cash flows from investing activities
Investments in property, plant and equipment
-5,398
-4,981
-13,911
-13,511
-12,727
Net cash used for investing activities
-5,398
-4,981
-13,911
-13,511
-12,725
Cash flows from financing activities
Debt repayment
-158,591
-158,601
-100,036
-34
-13,982
Common stock issued
-
0
64,645
121,144
131,195
Other financing activities
-18,328
-16,492
-7,682
-62
-830
Net cash used provided by (used for) financing activities
-39,786
-38,989
108,852
121,048
143,897
Net change in cash
-23,879
-35,170
35,433
-4,832
29,169
Cash at beginning of period
69,204
86,522
51,089
55,921
26,752
Cash at end of period
45,325
51,352
86,522
51,089
55,921
Free cash flow
Operating cash flow
21,305
8,800
-59,508
-112,369
-102,003
Capital expenditure
-5,398
-4,981
-13,911
-13,511
-12,727
Free cash flow
15,907
3,819
-73,419
-125,880
-114,730